Goldenwell Biotech, Inc. (GWLL)
1.05
0.00 (0.00%)
USD |
OTCM |
Feb 11, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 103.95M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 425.0% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 1630.86 |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -2.910 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | -- |
Profile
| Goldenwell Biotech, Inc. is a development stage company, which engages in the research & development and industrialization of healthcare products, bio-pharmaceuticals and bio-engineering drugs, and food and cosmetics products. The firm plans to develop, manufacture and market five products: Bovine Cardiac Vascular Active Peptide, Double Proline AG-3D Active Collagen Peptide, Cartilage Peptide-Type II Collagen Peptide, DNA Repair, and Sugar Master. The company was founded on August 20, 2019 and is headquartered in Solon, OH. |
| URL | N/A |
| Investor Relations URL | N/A |
| HQ State/Province | Ohio |
| Sector | |
| Industry | |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Goldenwell Biotech, Inc. is a development stage company, which engages in the research & development and industrialization of healthcare products, bio-pharmaceuticals and bio-engineering drugs, and food and cosmetics products. The firm plans to develop, manufacture and market five products: Bovine Cardiac Vascular Active Peptide, Double Proline AG-3D Active Collagen Peptide, Cartilage Peptide-Type II Collagen Peptide, DNA Repair, and Sugar Master. The company was founded on August 20, 2019 and is headquartered in Solon, OH. |
| URL | N/A |
| Investor Relations URL | N/A |
| HQ State/Province | Ohio |
| Sector | |
| Industry | |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |